Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.690
+0.510 (12.20%)
At close: Sep 9, 2024, 4:00 PM
4.700
+0.010 (0.21%)
Pre-market: Sep 10, 2024, 5:44 AM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $427.07 million as of September 10, 2024. Its market cap has increased by 286.49% in one year.
Market Cap
427.07M
Enterprise Value
372.92M
1-Year Change
286.49%
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $385.20M to $427.07M, an increase of 10.87%. That is a compound annual growth rate of 1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2024 | 427.10M | 216.60% |
| Dec 29, 2023 | 134.90M | 176.43% |
| Dec 30, 2022 | 48.80M | -68.76% |
| Dec 31, 2021 | 156.20M | -13.17% |
| Dec 31, 2020 | 179.90M | 23.39% |
| Dec 31, 2019 | 145.80M | -7.19% |
| Dec 31, 2018 | 157.10M | -59.22% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 391.87M |
| Fate Therapeutics | 386.05M |
| Aura Biosciences | 385.94M |
| Zevra Therapeutics | 385.16M |
| Canopy Growth | 381.37M |
| Korro Bio | 379.39M |
| Immutep | 378.64M |
| G1 Therapeutics | 377.11M |